NOV 19, 2015 7:30 PM PST

New Mechanism Found for Aspirin's Role in Cancer Prevention

WRITTEN BY: Julianne Chiaet
Scientists have known for a while that taking low daily doses of aspirin decreases the odds of a person having a heart attack, stroke, and many types of cancer. The types of cancer include prostate, lung, colorectal, and esophageal. These studies looked at the anti-inflammatory and anti-clotting roles of aspirin due to the fact that cancer patients are at a higher risk for blood clots, and inflammation plays a major role in the development of cancer.

Still, concerns over the drug’s side effects kept many doctors from recommending it to patients as a preventative measure. Serious, albeit rare, side effects include severe gastrointestinal bleeding, inflammation of the stomach, and vertigo.
 
Generic regular strength enteric coated 325mg aspirin tablets


Researchers at the Huntsman Cancer Institute wanted be able to tailor aspirin to people who would benefit the most and be at the smallest risk of side effects, says Cornelia Ulrich, Senior Director of Population Sciences at Huntsman Cancer Institute in Salt Lake City.

In a new study published in the journal Cancer Epidemiology, Biomarkers, and Prevention, Ulrich and her team of researchers found that aspirin plays a key role in interrupting multiple pathways that are linked to cancer development.

The researchers used a new technique to identify a new metabolic pathway, which is a series of chemical reactions that occur within a cell. The technique, called metabolite profiling, is an analytical method for quantifying metabolites from biological samples.

The study was divided into two parts. The first part of the study involved evaluating the metabolic profiles of blood from 40 individuals who took aspirin for 60 days. Each participant had a phase taking and not taking aspirin. The researchers analyzed over 360 metabolites. “This study covered most of the known biochemical pathways in the body,” Ulrich says.

They noticed a significant decrease of 2-hydroxyglurate in cultured cancer cells. The chemical 2-hydroxyglutarate is considered a driver of cancer development. Elevated levels of the chemical have been found in certain blood and brain cancers. They followed-up this finding in the second part of the study.

The team used colorectal (colon) cancer cell lines. Colorectal cancer is the third most common type of cancer in the United States. They treated the cells with aspirin and found that the primary metabolite of aspirin (salicylate) restrains an enzyme that triggers the production of 2-hydroxyglutarate. The drug ultimately decreased the level of 2-hydroxyglutarate in two colorectal (colon) cancer cell lines by up to 34 percent.

While this is promising, the researchers have only observed the changes in 2-hydroglurate levels in culture cancer cells and in blood plasma. Additional studies are necessary to see whether these changes are present in actual colon tissue.

Sources: Huntsman Cancer Institute at the University of Utah via Newswise
About the Author
  • Julianne (@JuliChiaet) covers health and medicine for LabRoots. Her work has been published in The Daily Beast, Scientific American, and MailOnline. While primarily a science journalist, she has also covered culture and Japanese organized crime. She is the New York Board Representative for the Asian American Journalists Association (AAJA). • To read more of her writing, or to send her a message, go to Jchiaet.com
You May Also Like
OCT 01, 2020
Health & Medicine
Menopausal Women Find Relief in Cannabis
OCT 01, 2020
Menopausal Women Find Relief in Cannabis
A growing number of women may be using cannabis for managing menopause symptoms, evidence from  the Midlife Women V ...
OCT 07, 2020
Neuroscience
Researchers Discover Molecular Mechanism for Memory Formation
OCT 07, 2020
Researchers Discover Molecular Mechanism for Memory Formation
Researchers from MIT have found that when the brain forms a new memory, neurons known as 'engram cells' encode t ...
OCT 13, 2020
Immunology
Why Halloween Is Extra Scary for Kids With Peanut Allergies
OCT 13, 2020
Why Halloween Is Extra Scary for Kids With Peanut Allergies
A recent study showed that there is an 85 percent spike in peanut allergy anaphylaxis cases on Halloween. The study, per ...
OCT 11, 2020
Microbiology
Getting Closer to a Vaccine for Flaviviruses
OCT 11, 2020
Getting Closer to a Vaccine for Flaviviruses
Flaviviruses like dengue, West Nile, Zika, Japanese Encephalitis, and yellow fever infect over 400 million people a year ...
OCT 11, 2020
Plants & Animals
Fungal Disease Affecting Snakes Is More Widespread Than Thought
OCT 11, 2020
Fungal Disease Affecting Snakes Is More Widespread Than Thought
A team of researchers and personnel on military bases have reported in a project in which they looked for an emerging fu ...
OCT 15, 2020
Genetics & Genomics
Gene Variants Influence Aging and Mobility in the Elderly
OCT 15, 2020
Gene Variants Influence Aging and Mobility in the Elderly
Small changes in a gene that is involved in controlling the levels of the neurotransmitter dopamine could influence how ...
Loading Comments...